Compare LEXX & QCLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEXX | QCLS |
|---|---|---|
| Founded | 2004 | 2014 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7M | 7.1M |
| IPO Year | 2011 | 2013 |
| Metric | LEXX | QCLS |
|---|---|---|
| Price | $2.86 | $0.56 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 72.9K | ★ 5.8M |
| Earning Date | 11-27-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 22.33 |
| EPS | ★ N/A | N/A |
| Revenue | $705,923.00 | ★ $3,929,527.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6,915.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 52.05 | 32.71 |
| 52 Week Low | $0.35 | $0.42 |
| 52 Week High | $21.60 | $11.80 |
| Indicator | LEXX | QCLS |
|---|---|---|
| Relative Strength Index (RSI) | 35.35 | 26.85 |
| Support Level | $2.79 | $0.42 |
| Resistance Level | $12.98 | $1.18 |
| Average True Range (ATR) | 0.42 | 0.10 |
| MACD | 0.20 | 0.04 |
| Stochastic Oscillator | 11.57 | 2.34 |
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.
Q/C Technologies Inc is engaged in building blockchain and cryptocurrency infrastructure that is faster and more energy-efficient through quantum-class laser-based computing. The company uses laser-based processors inspired by quantum technology that can solve complex problems. By combining photonic computing with cryptocurrency systems, the company creates powerful and sustainable solutions for the next generation of blockchain applications.